Acute and chronic effects of adriamycin on fatty acid oxidation in isolated cardiac myocytes

Journal of Molecular and Cellular Cardiology

Volumn 29, Issue 2, 1997, Pages 789-797

  Abdel Aleem, Salah ^a   El Merzabani, Mahmoud M ^a   Sayed Ahmed, Mohamed ^a   Taylor, Doris A ^a   Lowe, James E ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adriamycin; Cardiotoxicity; Fatty acid oxidation; L carnitine

Indexed keywords

BUTYRIC ACID; CARNITINE; CARNITINE PALMITOYLTRANSFERASE; DOXORUBICIN; FATTY ACID; GLUCOSE; OCTANOIC ACID; PALMITIC ACID; PALMITOYL COENZYME A; PALMITOYLCARNITINE; PYRUVIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; FATTY ACID OXIDATION; HEART MITOCHONDRION; HEART MUSCLE CELL; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031080688     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1996.0323     Document Type: Article

References (37)

1. ABDEL-ALEEM S, SCHULZ H, 1987. Evaluation of inhibitors of fatty acid oxidation in rat myocytes. Biochem Pharmacol 36: 4307-4312.
2. ABDEL-ALEEM S, YOUSSEE J, BADR M, FRANGAKIS CJ, 1992. The inhibition of long-chain fatty acyl-CoA synthetase by enoximone in rat heart mitochondria. J Cardiovasc Pharmacol 19: 899-904.
3. BARAKAT H, BROWN W, HENRY SD, 1978. Studies of fatty acid oxidation in homogenates of the cardiomyopathic hamster. Life Sci 23: 1835-1840.
4. BATTELLI D, BELLEI M, ARRIGONI-MARTELLI E, MUSCATELLO U, BOBYLEVA V, 1992. Interaction of carnitine with mitochondrial cardiolipin. Biochemica et Biophysica Acta 1117: 33-36.
5. BEANLANDS RSB, SHAIKH NA, WEN W, DAWOOD F, UGNAT A, MCLAAUGHLIN PR, CARERE R, LIU PP, 1994. Alteration in fatty acid metabolism in adriamycin cardiomyopathy. J Mol Cell Cardiol 26: 109-119.
6. BRADY LJ, BRADY PS, 1987. Hepatic and cardiac carnitine palmitoyltransferase activity. Effects of adriamycin and galactosamine. Biochem Pharmacol 36: 3419-3423.
7. BUZADAR AV, MARCUS CS, SMITH TL, BLUMENSCHEIN GR, 1985. Early and delayed clinical cardiotoxicity of doxorubicin. Cancer 55: 2761-2765.
8. CARTER SK, 1975. Adriamycin - a review. J Natl Cancer Inst 55; 1265-1274.
9. CARTER AL, PIERCE R, CULBREATH C, HOWARD E, 1992. Conjunctive enhancement of adriamycine by carnitine. In: A. L. Carter (ed.). Current Concepts in Carnitine Research. 245-251.
10. CHAPPEL JB, HANSFORD RG, 1969. In: G Birnie (eds). Subcellular Components. London: Butterworth, 77-91.
11. CORR PB, GROSS RS, SOBEL BE, 1985. Amphipathic metabolites and membrane dysfunction in ischemic myocardium. Circ Res 55: 135-154.
12. FRANGAKIS CJ, BAHL JJ, MCDANIEL H, BRESSLER R, 1980. Tolerance to physiological calcium by isolated myocytes from the adult rat heart: An improved cellular preparation. Life Sci 27: 815-825.
13. GOORMAGHTIGH E, BRASSEUR R, RUYSSCHAERT JM, 1982. Adriamycin inactivates cytochrome oxidase by exclusion of the enzyme from its cardiolipin essential environment. Biochem Biophys Res Commun 104: 314-320.
14. GOORMAGHTIGH E, RUYSSCHAERT JM. 1984. Anthracycline glycoside-membrane interactions. Biochim Biophys Acta 779: 271-288.
15. KAKO KJ, THORNTON MJ, HEGGTVEIT HA, 1974. Depressed fatty acid and acetate oxidation and other metabolic defects in homogenates from hearts of hamsters with hereditary cardiomyopathy. Circ Res xxxiv: 570-580.
16. KANTROWITZ NE, BRISTOW MR, 1984. Cardiotoxicity of antitumor agents. Prog Cardiovasc Dis 27: 195-200.
17. KASHFI K, ISRAEL M, SWEATMAN TW, SEAHADRI R, COOK GA, 1990. Inhibition of mitochondrial carnitine palmitoyl-transferase by adriamycin and adriamycin analogues. Biochem Biopharmcol 40: 1441-1448.
18. KATZ AM, MESSINEO FC, 1981. Lipid-membrane interactions and the pathogenesis of ischemic damage in the myocardium. Circ Res 48: 1-16.
19. LAW J, FUMAGALLI A, SCHEIN PS, RAHMAN A, 1985. Selective inhibition of cardiac cyclic nucleotide phosphodiesterases by doxorubicin and daunorubicin. Life Sci 36: 589-599.
20. LEFRAK EA, PITHA J, ROSENHIEM J, GOTIBIEB JH, 1973. A clincopathological analysis of adriamycin carditoxicity. Cancer 32: 303-309.
21. LYSIAK W, LILLY K, DILISA F, TOTH PP, BIEBER LL, 1988. Quantitation of the effects of L-carnitine on the levels of acid-soluble short-chain acyl-CoA and CoA-SH in rat heart and liver mitochondria. J Biol Chem 263: 1151-1156.
22. MACCARI F, RAMACCI MT. 1981. Antagonism of doxorubicin cardiotoxicity by carnitine is specific of the L-diasteroisomer. Biomedicine 35: 65-67.
23. MCFALLS EO, PAULSON DJ, GILBERT EF, SHUG AL, 1985. Carnitine protection against adriamycin-induced cardiomyopathy in rats. Life Sci 38: 497-505.
24. NEELY JR, MORGAN HE, 1974. Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Annu Rev Physiol 36: 413-459.
25. NERI B, CINI-NERI G, BARTALUCCI S, BANDINELLI M, 1986. Protective effect of L-carnitine on cardiac metabolic damage induced by doxorubicin in vivo. Anticancer Res 6: 659-662.
26. NICOLAY K, TIMMERS RJM, SPOELSTRA E, VAN DER NEUT R, FOK J, HUIGEN YM, VERKLEIJ AJ, DE KRUIJFF B. 1984. The interaction of adriamycin with cardiolipin in model and rat liver mitochondrial membranes. Biochem Biophys Acta 778: 359-371.
27. PATERNA S, FURITANO G, SCAFFIDI L, BARBARINO C, CAMPISI G, CARRECA I. 1984. Effects of L-carnitine on adriamycin-induced cardiomyopathy in rabbit. Int J Tiss Reac VI: 91-95.
28. SCHULZ H, 1985. Fatty acid oxidation. In: Vance DE, Vance JE (eds). Biochemistry of Lipids and Membranes. Menlo Park, CA: Benjamin-Cummings, 116-142.
29. SINGAL PK, DEALLY C, WEINBERG L, 1987. Subcellular effects of adriamycin in the heart: a concise review. J Mol Cell Cardiol 19: 543-553.
30. SINGAL PK, PANAGIA V, 1984. Direct effects of adriamycin on rat heart sarcolemma. Res Commun Chem Pathol Pharmacol 43: 67-77.
31. SINGAL PK, PIERCE GN, 1986. Adriamycin stimulates low affinity Ca++ binding and lipid peroxidation but depresses myocardial function. Am J Physiol 250: H419-H425.
32. TRIPP M, KATCHER M, PETERS H, GILBERT EF, ARYA S, HODACH RJ, SHUG AL, 1981. Systemic carnitine deficiency presenting as familial fibroelastosis. N Engl J Med 305: 385-390.
33. UZIEL G, GARAVAGLIA B, DI DONATO S, 1988. Carnitine stimulation of pyruvate dehydrogenase complex (PDHC) in isolated human skeletal muscle mitochondria. Muscle and Nerve 11: 720-724.
34. WHITMER JT, 1986. Energy metabolism and mechanical function in perfused hearts of Syrian hamsters with dilated or hypertrophic cardiomyopathy. J Mol Cell Cardiol 18: 307-317.
35. WHITMER JT. 1987. L-carnitine treatment improves cardiac performance and restores high-energy phosphate pools in cardiomyopathic syrian hamster. Circ Res 61: 396-408.
36. YANG S-Y, X-Y H AND SCHULZ H, 1987. Fatty acid oxidation in rat brain is limited by the low activity of 3-ketoacyl-Coenzyme A thiolase. J Biol Chem 262: 13027-13032.
37. YORK CM, CANTRELL CR AND BORUM PR, 1983. Cardiac carnitine deficiency and altered carnitine transport in cardiomyo-pathic hamsters. Arch Biochem Biophys 221: 526-533. J Mol Cell Cardiol 29, 799-811 (1997)